Skip to main content

ASP Isotopes Inc.

ASPI
Exchange
Nasdaq
Industry
Miscellaneous Chemical Products
SEC CIK
0001921865

In the last 90 days, ASP Isotopes Inc. insiders filed 2 open-market purchases and 7 sales; 160 institutions reported holding it in 13F filings for Q3 2026, worth $165.1M in total; no superinvestor holds it.

Currency
USD
Source
SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
Updated
Nov 17, 2026, 2:23 AM ET

Revenue flow, FY2025

Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.

Net loss for FY2025: $159.8M (670.2% of revenue).

Income statement

Each column is one fiscal year, newest first.

Income statement of ASP Isotopes Inc., annual
Line itemFY2025FY2024FY2023FY2022
Period endDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022
Filing10-K10-K10-K10-K
Reported––––
Revenue$23.8M$4.14M$433.0K–
Cost of revenue$20.4M$2.54M$294.1K–
Gross profit$3.40M$1.60M$139.0K–
Operating expenses$63.3M$28.0M$16.2M$5.10M
Research and development$12.4M$3.14M$764.6K$1.27M
Selling, general and administrative$48.2M$24.8M$15.4M$3.83M
Operating income-$59.9M-$26.4M-$16.0M-$5.10M
Interest expense$9.38K$17.9K$118.5K–
Income tax$282.0K$111.4K-$6.13K$0
Net income-$159.8M-$32.4M-$16.3M-$4.95M
EPS, basic$-2.11$-0.63$-0.49$-0.18
EPS, diluted$-2.11$-0.63––
Weighted shares, basic83.0M55.7M–26.8M
Weighted shares, diluted83.0M55.7M––
Margins and growth
Gross margin14.3%38.6%32.1%–
Operating margin-251.2%-635.9%-3704.6%–
Net margin-670.2%-782.4%-3762.9%–
Revenue growth, year over year+475.5%+857.0%––

Balance sheet

Each column is one fiscal year, newest first.

Balance sheet of ASP Isotopes Inc., annual
Line itemFY2025FY2024FY2023FY2022
Period endDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022
Filing10-K10-K10-K10-K
Reported––––
Cash and equivalents$285.6M$61.9M–$2.39M
Short-term investments$47.7M–––
Inventory$1.10M$65.7K––
Total current assets$399.9M$65.7M$10.5M$3.30M
Property, plant and equipment$33.5M$22.4M$10.7M$8.20M
Goodwill$8.57M$3.17M$3.27M–
Intangible assets$1.48M–––
Total assets$498.0M$94.3M$27.5M$12.5M
Accounts payable$5.75M$1.02M$1.11M$1.35M
Short-term debt$12.9M–––
Total current liabilities$32.7M$7.06M$5.67M$1.94M
Long-term debt$1.47M–––
Total liabilities$235.1M$43.2M$8.71M$2.68M
Shareholders' equity$262.9M$51.2M$18.8M$9.82M

Cash flow statement

Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.

Cash flow statement of ASP Isotopes Inc., annual
Line itemFY2025FY2024FY2023FY2022
Period endDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022
Filing10-K10-K10-K10-K
Reported––––
Operating cash flow-$37.8M-$16.7M-$5.41M-$2.94M
Capital expenditures$9.65M$9.68M$2.33M$4.47M
Free cash flow-$47.4M-$26.4M-$7.74M-$7.41M
Depreciation and amortization$1.91M–––
Stock-based compensation$16.0M$8.56M$8.74M$2.00M
Dividends paid$0$2.78M––
Investing cash flow-$110.8M-$11.4M-$2.45M-$4.47M
Financing cash flow$371.6M$82.5M$13.4M$6.64M
Net change in cash––$5.52M–
Ratio
Stock-based compensation, % of revenue67.2%206.6%2019.2%–

Shares outstanding

Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.

Shares outstanding for ASP Isotopes Inc. by cover date
Cover dateShares outstandingChange in a yearFiling
Nov 16, 2026155.8M+40.6%SEC
Aug 14, 2026153.3M+66.8%SEC
May 20, 2026125.9M+67.7%SEC
Apr 6, 2026125.9M+74.7%SEC
Nov 19, 2025110.8M+55.3%SEC
Aug 14, 202591.9M+37.8%SEC
May 20, 202575.1M+45.0%SEC
Mar 31, 202572.1M+47.3%SEC

Notes and known gaps

How these numbers are put together, and what they can't tell you.

  • Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
  • Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.

Known gaps

  • Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
  • EPS and share counts are as reported at the time, not adjusted for later stock splits.
  • For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
  • For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
  • Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
  • Depreciation and amortization is missing for some companies that report it under their own XBRL tags.